Kimberly-Clark(KMB)
Search documents
Kimberly-Clark to Acquire Kenvue
Yahoo Finance· 2025-11-03 11:47
Core Viewpoint - Kenvue Inc. is being acquired by Kimberly-Clark Corp. for $48.7 billion, marking a swift end to its time as a stand-alone public company after being spun out from Johnson & Johnson in 2023 [3][2]. Company Overview - Kenvue's brand portfolio includes well-known names such as Neutrogena, Aveeno, OGX, and Tylenol [2]. - The company initiated a strategic review to unlock shareholder value and assess its portfolio following the departure of its CEO [2]. Acquisition Details - The acquisition by Kimberly-Clark is expected to close in the second half of 2026, pending regulatory approvals [3]. - Kimberly-Clark's CEO expressed excitement about creating a global health and wellness leader through this merger, emphasizing Kenvue's unique position at the intersection of consumer packaged goods (CPG) and healthcare [4]. Market Reaction - Following the announcement, Kenvue's shares rose by 14%, while Kimberly-Clark's shares fell by 13.9% [4]. Strategic Implications - Analysts suggest that Kimberly-Clark is betting on the resolution of the Tylenol controversy and aims to manage a more diverse portfolio of brands, including ten billion-dollar brands [5]. - The Tylenol controversy involves legal scrutiny regarding claims that acetaminophen may lead to autism when taken during pregnancy, which has raised concerns about Kenvue's marketing practices [6]. Company Response - Kenvue has expressed concern over misinformation regarding acetaminophen safety and has conducted thorough reviews of the acquisition, consulting with experts to ensure it represents a generational value creation opportunity [7].
Kimberly-Clark to Buy Tylenol Maker Kenvue
WSJ· 2025-11-03 11:44
Group 1 - The deal is valued at $48.7 billion, including debt [1] - The transaction combines the maker of Huggies diapers with the owner of a painkiller manufacturer [1]
Kimberly-Clark to acquire Kenvue in $48.7 billion deal
Reuters· 2025-11-03 11:36
Core Viewpoint - Kimberly-Clark announced its intention to acquire Kenvue, the maker of Tylenol, in a deal valued at approximately $48.7 billion [1] Company Summary - The acquisition will enhance Kimberly-Clark's portfolio by integrating Kenvue's well-known consumer health products [1] - This strategic move is expected to strengthen Kimberly-Clark's position in the consumer health market [1] Industry Summary - The deal reflects ongoing consolidation trends within the consumer health sector, as companies seek to expand their product offerings and market reach [1] - The acquisition is indicative of the growing importance of health-related products in consumer markets, particularly in the wake of increased health awareness [1]
Kimberly-Clark to Acquire Kenvue, Creating a $32 Billion Global Health and Wellness Leader
Prnewswire· 2025-11-03 11:30
Core Viewpoint - Kimberly-Clark Corporation is acquiring Kenvue Inc. in a cash and stock transaction valued at approximately $48.7 billion, aiming to create a global leader in consumer health and wellness with a portfolio of 10 iconic billion-dollar brands [1][2][8] Transaction and Financial Details - The acquisition values Kenvue at an enterprise value of approximately $48.7 billion, representing an acquisition multiple of about 14.3x Kenvue's last twelve months (LTM) adjusted EBITDA or 8.8x including expected run-rate synergies of $2.1 billion [1][8] - Kenvue shareholders will receive $3.50 per share in cash and 0.14625 Kimberly-Clark shares for each Kenvue share held, totaling $21.01 per share [8] - The combined company is projected to generate annual net revenues of approximately $32 billion and about $7 billion of adjusted EBITDA in 2025 [8] Strategic Benefits - The merger combines two complementary portfolios, enhancing exposure to key categories benefiting from health and wellness trends [8] - The transaction is expected to deliver total anticipated run-rate synergies of $2.1 billion, with approximately $1.9 billion in cost synergies and $500 million in incremental profit from revenue synergies [8] - Kimberly-Clark's commercial activation engine and Kenvue's science-backed innovation will be leveraged to accelerate growth and address unmet consumer needs [8] Leadership and Governance - Mike Hsu will serve as the Chairman and CEO of the combined company, with three members from Kenvue's Board joining Kimberly-Clark's Board [12]
Kimberly-Clark Corporation 2025 Q3 - Results - Earnings Call Presentation (NASDAQ:KMB) 2025-10-31
Seeking Alpha· 2025-10-31 07:01
Group 1 - The article does not provide any specific content or key points related to a company or industry [1]
KMB Q3 Earnings Beat Estimates, Sales In Line With the Year-Ago Level
ZACKS· 2025-10-30 15:36
Core Insights - Kimberly-Clark Corporation (KMB) demonstrated resilient consumer demand and steady volume growth in Q3 2025, despite ongoing margin pressures, with results aligning closely with the previous year's performance under its Powering Care strategy [1] Financial Performance - Adjusted earnings per share (EPS) for Q3 2025 were $1.82, matching the prior year's figure and exceeding the Zacks Consensus Estimate of $1.45 [2] - Net sales reached $4.2 billion, consistent with the prior year, despite a 2.2% negative impact from exiting the private-label diaper business in the U.S. Organic sales increased by 2.5%, supported by a 2.4% rise in volume [3] - The adjusted gross margin was 36.8%, down 170 basis points year over year, primarily due to cost inflation and tariff-related expenses [4] - Adjusted operating profit was $683 million, remaining flat compared to the previous year, with reduced expenses offsetting gross margin challenges [4] Segment Performance - The North America segment reported net sales of $2.7 billion, a decrease of 0.8%, while organic sales grew by 2.7% driven by a 2.6% volume increase [6] - The International Personal Care segment achieved $1.4 billion in sales, up 1.9%, with organic sales growth of 2.1% [7] Financial Health - At the end of the quarter, Kimberly-Clark had cash and cash equivalents of $617 million, long-term debt of $6.47 billion, and total stockholders' equity of $1.468 billion [8] - Year-to-date cash provided by operations was $1.8 billion, with capital spending totaling $741 million and $1.4 billion returned to shareholders through dividends and buybacks [8] Future Outlook - For 2025, organic sales growth is expected to align with market trends at around 2%, with reported net sales facing headwinds from currency movements and business divestitures [11] - Adjusted operating profit is forecasted to rise at a low single-digit rate on a constant-currency basis, impacted by divestitures and unfavorable foreign exchange [12] - Adjusted EPS is anticipated to increase at a low-to-mid single-digit rate, incorporating various impacts from divestitures and higher interest expenses [13] - Management projects adjusted free cash flow of approximately $2 billion for 2025 [14]
Kimberly-Clark(KMB) - 2025 Q3 - Quarterly Report
2025-10-30 15:28
Financial Performance - Net sales for the three months ended September 30, 2025, were $4.15 billion, a slight increase of 0.1% compared to $4.14 billion in 2024, while net sales for the nine months ended September 30, 2025, declined by 2.6% to $12.37 billion from $12.70 billion in 2024[95]. - Gross profit for the three months ended September 30, 2025, was $1.49 billion, down 4.5% from $1.56 billion in 2024, and for the nine months, it decreased by 8.0% to $4.46 billion from $4.84 billion[95]. - Operating profit for the three months ended September 30, 2025, was $621 million, a decrease of 39.5% from $1.03 billion in 2024, while for the nine months, it fell by 19.1% to $1.84 billion from $2.28 billion[95]. - The company reported a pre-tax gain of $566 million from the sale of its former PPE business, contributing to a net income attributable to Kimberly Clark Corporation of $446 million for the three months ended September 30, 2025, down 50.8% from $907 million in 2024[91][95]. - Income from continuing operations for the three and nine months ended September 30, 2025 was $344 million and $1.3 billion, respectively, down from $823 million and $1.8 billion in the prior year[108]. - Diluted earnings per share for the three and nine months ended September 30, 2025 were $1.01 and $3.73, respectively, representing a decrease of 58.3% and 30.5% compared to the prior year[112]. Sales and Growth - Organic sales growth for the three months ended September 30, 2025, was 2.5%, driven by volume gains of 2.4%, while net sales for the nine months showed a 1.6% organic increase[99][100]. - Net sales for North America for the three months ended September 30, 2025 were $2.7 billion, a decrease of 0.8% due to the exit of the private label diaper business[119]. - Net sales for International Personal Care for the three months ended September 30, 2025 were $1.4 billion, an increase of 1.9% primarily due to a 2.1% increase in organic sales[121]. - Organic Sales Growth for the three months ended September 30, 2025, was 2.7%, while for the nine months it was 2.1%[142]. Cost and Expenses - The company anticipates incremental costs of approximately $100 million in 2025 due to new tariffs, primarily affecting the North America segment[86]. - The gross margin for the three months ended September 30, 2025, was 36.0%, a decrease of 170 basis points compared to the prior year, primarily due to unfavorable pricing and cost inflation[101][102]. - Cash provided by operations was $1.8 billion during the nine months ended September 30, 2025, down from $2.4 billion in the prior year[124]. - Cash used for investing was $650 million during the nine months ended September 30, 2025, compared to cash provided by investing of $94 million in the prior year[125]. - Total debt from continuing operations was $7.3 billion as of September 30, 2025, slightly down from $7.4 billion at the end of 2024[128]. - The company anticipates full year capital spending to be approximately $1.0 to $1.2 billion, including incremental spending from the 2024 Transformation Initiative[125]. Tax and Adjustments - The effective tax rate for the three and nine months ended September 30, 2025 was 45.4% and 30.6%, respectively, compared to 19.4% and 19.1% in the prior year[110]. - Adjusted operating profit for the three months ended September 30, 2025, was $683 million, a slight increase from $682 million in 2024, while for the nine months, it decreased to $2.10 billion from $2.17 billion[96][103]. - Adjusted Gross Profit for the three months ended September 30, 2025, was $1,527 million, compared to $1,595 million in 2024[144]. - Adjusted Earnings per Share for the three months ended September 30, 2025, was $1.45, compared to $1.56 in 2024[144]. - The effective tax rate as reported for the nine months ended September 30, 2025, was 30.6%[146]. Strategic Initiatives - The 2024 Transformation Initiative is expected to yield total pre-tax savings of $3.0 billion, with total costs anticipated to be approximately $1.5 billion pre-tax, of which cash costs are expected to be around 60%[90]. - The 2024 Transformation Initiative aims to enhance agility and focus, improving growth trajectory and profitability[143]. - The company recognized a deferred tax liability related to the IFP Transaction for certain permanently reinvested earnings expected to be repatriated[143]. - The sale of the PPE business in 2024 resulted in a recognized gain, contributing positively to financial results[143]. - Impairment charges related to intangible assets were recognized in 2024, impacting overall profitability[143]. - The company anticipates challenges from external factors such as currency fluctuations and geopolitical risks affecting future performance[134].
Kimberly-Clark(KMB) - 2025 Q3 - Earnings Call Transcript
2025-10-30 13:02
Financial Data and Key Metrics Changes - The third quarter results indicate strong progress in transforming Kimberly-Clark into an industry-leading personal care company, with consistent operating margin expansion and industry-leading productivity [4][5] - The company achieved its seventh consecutive quarter of volume plus mix-led growth, despite challenges in the broader consumer packaged goods (CPG) industry [4][5] Business Line Data and Key Metrics Changes - In North America, Kimberly-Clark gained 10 basis points of market share in diapers during the third quarter, with a year-to-date increase of 90 basis points [9][10] - The promotional activity in North America is lower than pre-2019 levels, with a focus on driving trial for innovation [10][11] Market Data and Key Metrics Changes - The company is experiencing double-digit growth in the club channel, which is positively impacting its business [12][13] - Digital channels accounted for 100% of growth in North America, with a significant share benefit compared to brick-and-mortar [39][40] Company Strategy and Development Direction - Kimberly-Clark's strategy is centered on innovation-led growth, focusing on improving products across the good, better, best spectrum [8][10] - The company aims to achieve a gross margin of at least 40% and an operating profit of 18%-20% by the end of the decade [28][29] Management's Comments on Operating Environment and Future Outlook - Management noted that consumer purchasing power is under pressure, but demand for essential categories remains resilient [47][48] - The company is confident in its ability to mitigate stranded costs from the IFB transaction and expects to see a step-up in growth in adjusted EPS from continuing operations [28][29] Other Important Information - The company is working to stabilize fiber costs through a joint venture with Suzano, which is expected to reduce volatility in input costs [74][76] - The transition to integrated margin management is helping the company proactively manage cost volatility [76][77] Q&A Session Summary Question: Update on competitive dynamics in U.S. diapers - Management acknowledged increased competitive activity but noted solid performance and market share gains in diapers [8][9] Question: Shape of the P&L in 2026 and 2027 - Management indicated it is premature to provide specifics but highlighted targets for organic growth and operating profit consistent with long-term algorithms [26][28] Question: Performance gap in North America - Management explained that the gap was due to hurricane-related shipment impacts and timing of promotional expenses [37][38] Question: Promotional activity and margin implications - Management stated that promotional activity is a tactic to drive trial and that gross margins are expected to expand in Q4 [51][52] Question: Full 2025 guidance and top-line expectations - Management expects to grow in line with category growth and anticipates an acceleration in Q4 [60][62] Question: Competition in the ultra-premium diaper segment - Management expressed confidence in competing through innovation and premiumization strategies [69][70]
Kimberly-Clark(KMB) - 2025 Q3 - Earnings Call Transcript
2025-10-30 13:02
Financial Data and Key Metrics Changes - The third quarter results indicate strong progress in transforming Kimberly-Clark into an industry-leading personal care company, with consistent operating margin expansion and industry-leading productivity [5][6] - The company achieved volume plus mix-led growth for the seventh consecutive quarter, despite challenges in the broader consumer packaged goods (CPG) industry [5][6] - The company maintained global weighted market share in the fourth quarter despite increased competitive promotional activity [5][6] Business Line Data and Key Metrics Changes - In North America, Kimberly-Clark gained 10 basis points of market share in diapers during the third quarter, with a year-to-date increase of 90 basis points [12][12] - Promotional activity in North America is down compared to 2019 levels, with a focus on driving trial for innovation [13][15] - The company is experiencing double-digit growth in the club channel, which is positively impacting business performance [16] Market Data and Key Metrics Changes - The company noted a significant migration of consumers to e-commerce and club channels, with 100% of growth in digital channels coming from this segment [43][44] - Year-to-date shipments are largely in line with consumption, with specific impacts from last year's hurricane-related shipment issues [41][42] Company Strategy and Development Direction - Kimberly-Clark's strategy focuses on innovation-led growth and premiumization across all product tiers, aiming to meet consumer needs at every price point [10][73] - The company is committed to achieving long-term operating profit growth and gross margin targets of at least 40% by the end of the decade [32][81] - The partnership with Suzano is expected to stabilize fiber costs and reduce volatility in input costs [78][80] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in the company's ability to navigate competitive dynamics and maintain strong performance despite external pressures on consumer purchasing power [52][53] - The company anticipates continued organic growth ahead of its categories, with a focus on mitigating stranded costs from the IFB transaction expected to close mid-next year [31][32] Other Important Information - The company is targeting a gross margin of at least 40% and an operating profit of 18% to 20% by the end of the decade [32] - The company is actively managing tariff impacts, with a reduction in gross tariffs from $170 million to $100 million [59][60] Q&A Session Summary Question: Update on competitive dynamics in U.S. diapers - Management acknowledged increased competitive activity but noted solid performance and a slight market share gain in diapers [10][12] Question: Shape of the P&L in 2026 and 2027 - Management indicated it is premature to provide detailed guidance but emphasized targeting organic growth consistent with long-term algorithms [30][31] Question: Performance in North America relative to trends - Management explained that discrepancies in performance data may arise from different data sources and emphasized sustained momentum from innovation [38][41] Question: Promotional activity in North America - Management discussed the strategy of using promotions to drive trial and the expectation of gross margin expansion in Q4 [56][57] Question: Full 2025 guidance and top-line expectations - Management expects to grow in line with category growth, with an acceleration anticipated in Q4 [65][67] Question: Competing in the ultra-premium diaper market - Management expressed confidence in their technology and innovation pipeline, aiming to compete effectively across all product tiers [73][74]
Kimberly-Clark(KMB) - 2025 Q3 - Earnings Call Transcript
2025-10-30 13:00
Financial Data and Key Metrics Changes - The third quarter results indicate strong progress in transforming Kimberly-Clark into an industry-leading personal care company, with consistent operating margin expansion and industry-leading productivity [6][8] - The company achieved its seventh consecutive quarter of volume plus mix-led growth, despite challenges in the broader consumer packaged goods (CPG) industry [6][8] Business Line Data and Key Metrics Changes - In North America, Kimberly-Clark gained 10 basis points of market share in diapers during the third quarter, with a year-to-date increase of 90 basis points [15][19] - The promotional activity in North America is lower than pre-2019 levels, with a focus on driving trial for innovation rather than expanding categories [16][18] Market Data and Key Metrics Changes - The company is experiencing double-digit growth in the club channel, driven by consumer shifts and changes in assortment [19] - Digital channels accounted for 100% of growth in North America, with a 7-point share benefit compared to brick-and-mortar [44] Company Strategy and Development Direction - Kimberly-Clark's strategy is centered on innovation-led growth, focusing on improving products across the good, better, best spectrum [12][75] - The company aims to achieve a gross margin of at least 40% and an operating profit of 18% to 20% by the end of the decade [33][82] Management's Comments on Operating Environment and Future Outlook - Management noted that consumer purchasing power is under pressure, but demand for essential categories remains resilient [51] - The company is confident in its ability to mitigate stranded costs from the IFB transaction and expects to see a step-up in growth in adjusted EPS from continuing operations [32][34] Other Important Information - The company is working to reduce volatility in fiber costs through a joint venture with Suzano, which is expected to stabilize input costs [80][82] - The company is committed to driving premiumization across its product lines, with a significant increase in the premium mix in both North America and China [75][76] Q&A Session Summary Question: Update on competitive dynamics in U.S. diapers - Management acknowledged increased competitive activity but noted solid performance and a slight market share gain in diapers [12][15] Question: Shape of the P&L in 2026 and 2027 - Management indicated it is premature to provide detailed guidance but emphasized targeting organic growth ahead of categories [32][33] Question: Performance in North America relative to trends - Management explained that hurricane-related shipment dynamics and promotional timing contributed to stronger performance in the quarter [42][43] Question: Promotional activity in North America - Management stated that promotional activity is a tactic to drive trial and that they are focused on strengthening value propositions [51][52] Question: Cost outlook and tariff impacts - Management reported a reduction in gross tariffs and ongoing efforts to mitigate costs, expecting improvements in Q4 and early 2026 [59][60] Question: Competition in the ultra-premium diaper segment - Management expressed confidence in their technology and innovation pipeline, aiming to compete effectively across all tiers [75][76]